COMPARATIVE EFFECTIVENESS OF DENOSUMAB VERSUS ORAL BISPHOSPHONATES AMONG POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS IN THE US MEDICARE PROGRAM

被引：0
|
作者：
Curtis, J. [1 ]
机构：
[1] Univ Alabama Birmingham, Div Clin Immunol & Rheumatol, Birmingham, AL USA
来源：
AGING CLINICAL AND EXPERIMENTAL RESEARCH | 2023年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
SY6
引用
收藏
页码：S580 / S580
页数：1
相关论文
共 50 条
  • [41] Cost-effectiveness of denosumab for high-risk postmenopausal women with osteoporosis in Thailand
    Pongchaiyakul, Chatlert
    Nanagara, Ratanavadee
    Songpatanasilp, Thawee
    Unnanuntana, Aasis
    JOURNAL OF MEDICAL ECONOMICS, 2020, 23 (07) : 776 - 785
  • [42] Persistence with denosumab and persistence with oral bisphosphonates for the treatment of postmenopausal osteoporosis: a retrospective, observational study, and a meta-analysis
    Karlsson, L.
    Lundkvist, J.
    Psachoulia, E.
    Intorcia, M.
    Strom, O.
    OSTEOPOROSIS INTERNATIONAL, 2015, 26 (10) : 2401 - 2411
  • [43] A RANDOMIZED DOUBLE-BLIND STUDY OF DENOSUMAB (DMAB) COMPARED WITH ZOLEDRONIC ACID (ZOL) IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS PREVIOUSLY TREATED WITH ORAL BISPHOSPHONATES
    Miller, P.
    Pannacciulli, N.
    Brown, J. P.
    Czerwinski, E.
    Nedergaard, B. S.
    Bolognese, M. A.
    Malouf, J.
    Bones, H. G.
    Reginster, J. -Y.
    Singer, A.
    Wang, C.
    Wagman, R. B.
    Cummings, S. R.
    OSTEOPOROSIS INTERNATIONAL, 2016, 27 : S41 - S41
  • [44] EFFICACY OF ONCE-MONTHLY ORAL BISPHOSPHONATES (IBANDRONATE AND RISEDRONATE) IN WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS
    Epstein, S.
    McCloskey, E.
    OSTEOPOROSIS INTERNATIONAL, 2009, 20 : 146 - 146
  • [45] BMD CHANGE AFTER ONE YEAR OF TREATMENT WITH DENOSUMAB OR BISPHOSPHONATES IN POSTMENOPAUSAL WOMEN WITH SEVERE OSTEOPOROSIS PRETREATED WITH TERIPARATIDE
    Kocjan, T.
    SabatiRajic, A.
    JensterleSever, M.
    Ostanek, B.
    Orehek, N.
    Marc, J.
    Pfeifer, M.
    Prezelj, J.
    OSTEOPOROSIS INTERNATIONAL, 2016, 27 : S341 - S342
  • [46] A Meta-Analysis of 4 Clinical Trials of Denosumab Compared With Bisphosphonates in Postmenopausal Women Previously Treated With Oral Bisphosphonates.
    Miller, P.
    Pannacciulli, N.
    Malouf-Sierra, J.
    Singer, A.
    Czerwinski, E.
    Bone, H. G.
    Wang, C.
    Wagman, R. B.
    Brown, J. P.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2017, 32 : S271 - S271
  • [47] Comparative Effectiveness and Cost-Effectiveness of Strategies to Screen for Osteoporosis in Postmenopausal Women
    Schousboe, John T.
    Gourlay, Margaret L.
    ANNALS OF INTERNAL MEDICINE, 2011, 155 (11) : 788 - U117
  • [48] A Cost Effectiveness Analysis of Biosimilar Denosumab vs. Bisphosphonates for Women with Post-Menopausal Osteoporosis
    Flanigan, Jeanine
    Kane, Sarah
    Fashami, Fatemeh
    Zhou, Anna
    Almuallem, Lamees
    Tindal, Mike
    Schauf, Marion
    Lyman, Gary
    JOURNAL OF BONE AND MINERAL RESEARCH, 2024, 39 : 161 - 161
  • [49] Effect of Denosumab Three Years Therapy in Women with Osteoporosis and Contraindications to Oral Bisphosphonates on Bone Mineral Density
    Sawicki, Andrzej
    Janiak, Radoslaw
    Nawrot, Ireneusz
    Sawicki, Piotr
    JOURNAL OF BONE AND MINERAL RESEARCH, 2014, 29 : S325 - S325
  • [50] Cost-effectiveness of bisphosphonate therapies for women with postmenopausal osteoporosis: implications of improved persistence with less frequently administered oral bisphosphonates
    Earnshaw, S. R.
    Graham, C. N.
    Ettinger, B.
    Arnonkar, M. M.
    Lynch, N. O.
    Middelhoven, H.
    CURRENT MEDICAL RESEARCH AND OPINION, 2007, 23 (10) : 2517 - 2529
12345